NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Innoventric

Innoventric

Private
Ness ZionaHealthcare & Life Scienceshttps://innoventric.com/

Last Round

Series B

Oct 29, 2024

Total Funding Raised

$42.5M

Company Overview

Innoventric is a medical device company that develops transcatheter solutions for the treatment of tricuspid regurgitation and right heart disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

tricuspid regurgitationtranscatheter valve replacementstructural heartcross-caval technologyminimally invasive surgerymedical deviceinterventional cardiologypercutaneous valveTAVRvalve replacementcardiovascular implantclinical trialsstructural heart diseaseheart valve repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innoventric Comparables

Compare Innoventric with similar companies based on industry and business-model similarity.

Innoventric comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
P&F Products & Features GmbH
91%
CroíValve
89%
VDyne
87%

Innoventric Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 29, 2024
Series ANov 1, 2021

Key People

Founding team and executive leadership

Einat Har

Chief Financial Officer

Executive Team

Innoventric Investors

Notable investors and investment history

Innoventric investors
InvestorRounds
European Innovation Council FundSeries B, Series A
RA Capital ManagementSeries B
BRM GroupSeed, Series A, Series B
Mivtach Shamir HoldingsSeries B, Seed, Series A
JG InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    $29M round led by RA Capital Management.

Innoventric Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Innoventric Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Innoventric's valuation, stock price, and market status.

Firmographic Details

HeadquartersNess Ziona
Employee Range22
Year Founded2017
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.